Biofrontera (BFRI) Retained Earnings (2020 - 2025)
Biofrontera (BFRI) recorded quarterly Retained Earnings of -$127.9 million in Q4 2025, up 4.23% quarter-over-quarter from -$133.6 million in Q3 2025, and down 8.97% on a YoY basis from -$140.6 million in Q4 2024.
Biofrontera (BFRI) Retained Earnings (2020 - 2025) Analysis & Trends
Biofrontera's Retained Earnings history runs 6 years deep, the most recent figure standing at -$127.9 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 8.97% year-over-year to -$127.9 million; the TTM figure through Dec 2025 stood at -$127.9 million (down 8.97% YoY), while the FY2025 annual figure was -$127.9 million, down 8.97% from the prior year.
- Retained Earnings was -$127.9 million for Q4 2025 at Biofrontera, up from -$133.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$64.4 million in Q3 2021 to a low of -$133.6 million in Q3 2025.
- Historically, Retained Earnings has averaged -$100.0 million across 5 years, with a median of -$103.2 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Retained Earnings sank 91.61% in 2021, then retreated 0.81% in 2022.
- A 5-year view of Retained Earnings shows it stood at -$78.9 million in 2021, then retreated by 0.81% to -$79.5 million in 2022, then decreased by 25.32% to -$99.6 million in 2023, then decreased by 17.82% to -$117.4 million in 2024, then decreased by 8.97% to -$127.9 million in 2025.
- The last three Retained Earnings figures came in at -$127.9 million (Q4 2025), -$133.6 million (Q3 2025), and -$126.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Biofrontera | 8.65 Mn | 2.24 Mn | 14.09 Mn | -127.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -127.95 Mn |
| Sep 30, 2025 | -133.60 Mn |
| Jun 30, 2025 | -126.90 Mn |
| Mar 31, 2025 | -121.61 Mn |
| Dec 31, 2024 | -117.41 Mn |
| Sep 30, 2024 | -116.01 Mn |
| Jun 30, 2024 | -110.30 Mn |
| Mar 31, 2024 | -110.10 Mn |
| Dec 31, 2023 | -99.65 Mn |
| Sep 30, 2023 | -103.20 Mn |
| Mar 31, 2023 | -87.00 Mn |
| Dec 31, 2022 | -79.52 Mn |
| Sep 30, 2022 | -76.70 Mn |
| Jun 30, 2022 | -74.17 Mn |
| Mar 31, 2022 | -73.32 Mn |
| Dec 31, 2021 | -78.88 Mn |
| Sep 30, 2021 | -64.40 Mn |
| Dec 31, 2020 | -41.17 Mn |